Histone deacetylase inhibitors in hematological malignancies and solid tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12272-015-0571-1.pdf
Reference159 articles.
1. Adams, H., F.R. Fritzsche, S. Dirnhofer, G. Kristiansen, and A. Tzankov. 2010. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin’s lymphoma. Expert Opinion on Therapeutic Targets 14: 577–584.
2. Amann, J.M., J. Nip, D.K. Strom, B. Lutterbach, H. Harada, N. Lenny, J.R. Downing, S. Meyers, and S.W. Hiebert. 2001. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Molecular and Cellular Biology 21: 6470–6483.
3. Ashkenazi, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nature Reviews Cancer 2: 420–430.
4. Atsumi, A., A. Tomita, H. Kiyoi, and T. Naoe. 2006. Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML–RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo. Biochemical and Biophysical Research Communications 345: 1471–1480.
5. Bagnes, C., P.N. Panchuk, and G. Recondo. 2010. Antineoplastic chemotherapy induced QTc prolongation. Current Drug Safety 5: 93–96.
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6;International Journal of Molecular Sciences;2024-05-28
2. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity;Current Stem Cell Research & Therapy;2024-03-28
3. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation;International Journal of Molecular Sciences;2024-01-22
4. Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise;ACS Chemical Neuroscience;2024-01-12
5. Alterations of histone modifications in cancer;Epigenetics in Human Disease;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3